DENTSPLY SIRONA Inc.
NASDAQ:XRAYMedical - Instruments & Supplies
+$0.19 today
- Market cap
- $1.70B
- Beta
- 0.91
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$3.14
- Dividend yield
- 6.27%
Volume 5.40M
Average 4.70M
XRAY Other Stockholders Equity
Equity items not reported separately, such as additional paid-in capital or treasury stock.
DENTSPLY SIRONA Inc.NASDAQ: XRAY
Other Stockholders Equity · Q1 FY2026 · quarter ended Mar 2026
Other stockholders equity remains negative
Q1 FY2026 other stockholders equity was $0, compared with $0 a year earlier.
Context
- Other stockholders equity amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Other stockholders equity increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Stockholders Equity history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Other Stockholders Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Other Stockholders Equity vs competitors
How XRAY compares with its peers on the latest reported figures
- XRAY's Mar 2026 other stockholders equity of $0 is the 2nd highest of the 4 companies compared; the peer median is $0.
- Other stockholders equity amounts to 0.0% of total assets for XRAY, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Oct 2026 | $3.57B | — | — | 63.7% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding XRAY) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for XRAY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 339M | 365M | 334M | 272M | 326M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 803M | 685M | 756M | 606M | 688M |
| Inventory | 515M | 627M | 624M | 564M | 642M |
| Other Current Assets | 84M | 88M | 146M | 153M | 367M |
| Total Current Assets | 1.85B | 1.89B | 1.97B | 1.75B | 2.02B |
| Property, Plant & Equipment (Net) | 971M | 961M | 978M | 902M | 1B |
| Goodwill | 3.98B | 2.69B | 2.44B | 1.6B | 1.15B |
| Intangible Assets | 2.32B | 1.9B | 1.71B | 1.21B | 974M |
| Long-term Investments | 0 | 0 | 0 | 23M | 0 |
| Tax Assets | 0 | 0 | 228M | 0 | 0 |
| Other Non-current Assets | 121M | 198M | 48M | 278M | 284M |
| Total Non-current Assets | 7.39B | 5.75B | 5.4B | 4.01B | 3.41B |
| Total Assets | 9.24B | 7.64B | 7.37B | 5.75B | 5.43B |
| Account Payables | 262M | 279M | 305M | 241M | 300M |
| Short-term Debt | 182M | 118M | 322M | 549M | 360M |
| Tax Payables | 63M | 52M | 49M | 45M | 30M |
| Deferred Revenue | 68M | 84M | 91M | 95M | 74M |
| Other Current Liabilities | 212M | 182M | 169M | 64M | 408M |
| Total Current Liabilities | 1.26B | 1.17B | 1.43B | 1.59B | 1.34B |
| Long-term Debt | 1.91B | 1.83B | 1.8B | 1.59B | 2.02B |
| Deferred Tax Liabilities | 391M | 287M | 228M | 129M | 86M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 95M |
| Other Non-current Liabilities | 528M | 399M | 502M | 415M | 457M |
| Total Non-current Liabilities | 2.98B | 2.66B | 2.65B | 2.22B | 2.75B |
| Total Liabilities | 4.24B | 3.83B | 4.08B | 3.81B | 4.09B |
| Common Stock | 3M | 3M | 3M | 3M | 3M |
| Retained Earnings | 1.51B | 456M | 205M | (835M) | (1.56B) |
| Accumulated OCI | (592M) | (628M) | (636M) | (730M) | (639M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 1M | 1M | 1M | 1M | 1M |
| Total Equity | 5B | 3.81B | 3.29B | 1.94B | 1.34B |
| Total Debt | 2.29B | 2.15B | 2.3B | 2.27B | 2.47B |
| Net Debt | 1.96B | 1.78B | 1.97B | 2B | 2.14B |
DENTSPLY SIRONA Inc.
NASDAQ:XRAY
Intrinsic Alpha fair value
Locked
Current Price
$8.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.